Immune cell test may predict kidney graft problems

NCT ID NCT04414111

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether measuring a specific type of immune cell (called highly suppressive Treg) before a kidney transplant can predict if the new kidney will work slowly or need dialysis. Researchers will test blood samples from 180 adult kidney transplant candidates. The goal is to find a reliable biomarker to guide organ allocation and reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors match donated kidneys to patients less likely to have complications, and guide new immune-based treatments.

What could go wrong

This is an observational biomarker study, not a treatment trial. The test may not accurately predict outcomes, and results may not change clinical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Loma Linda University Health Transplantation Institute

    San Bernardino, California, 92408, United States

  • Saint Louis University

    St Louis, Missouri, 63110, United States